Rhesus pieces: Genotype matching of RBCs

Blood

Volumn 132, Issue 11, 2018, Pages 1091-1093

  Hendrickson, Jeanne E ^a   Tormey, Christopher A ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; BLOOD GROUP E ANTIGEN; RHESUS C ANTIBODY; RHESUS D ANTIGEN;

ALLELE; ALLOIMMUNIZATION; ANTIGEN ANTIBODY REACTION; ARTICLE; BLOOD DONOR; BLOOD GROUP RHESUS SYSTEM; BLOOD GROUP TYPING; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; GENETIC VARIABILITY; GENOTYPE; HUMAN; PRIORITY JOURNAL; BLOOD TRANSFUSION; SICKLE CELL ANEMIA;

ANEMIA, SICKLE CELL; BLOOD TRANSFUSION; ERYTHROCYTES; GENOTYPE; HUMANS;

EID: 85053132278     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2018-07-865634     Document Type: Article

References (10)

1. Chou ST, Evans P, Vege S, et al. RH genotype matching for transfusion support in sickle cell disease. Blood. 2018;132(11):1198-1207.
2. Chou ST, Jackson T, Vege S, Smith-Whitley K, Friedman DF, Westhoff CM. High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors. Blood. 2013; 122(6):1062-1071.
3. Vichinsky EP, Earles A, Johnson RA, Hoag MS, Williams A, Lubin B. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med. 1990;322(23): 1617-1621. cell disease. Transfusion. 2015;55(6 pt 2): 1399-1406.
4. US Department of Health and Human Services, National Institutes of Health, National Heart, Lung Blood Institute. Evidence-based management of sickle cell disease: expert panel report.; 2014. Available from: http://www.nhlbi.nih.gov/health-pro/guidelines/sickle-cell-disease-guidelines. Accessed 31 July 2018.
5. Silvy M, Tournamille C, Babinet J, et al. Red blood cell immunization in sickle cell disease: evidence of a large responder group and a low rate of anti-Rh linked to partial Rh phenotype. Haematologica. 2014;99(7): e115-e117.
6. Singhal D, Kutyna MM, Chhetri R, et al. Red cell alloimmunization is associated with development of autoantibodies and increased red cell transfusion requirements in myelodysplastic syndrome. Haematologica. 2017;102(12):2021-2029.
7. Yazer MH, Jackson B, Beckman N, et al; Biomedical Excellence for Safer Transfusions (BEST) Collaborative. Changes in blood center red blood cell distributions in the era of patient blood management: the trends for collection (TFC) study. Transfusion. 2016;56(8): 1965-1973.
8. Karafin MS, Field JJ, Gottschall JL, Denomme GA. Barriers to using mo-lecularly typed minority red blood cell donors in support of chronically transfused adult patients with sickle cell disease. Transfusion. 2015;55(6 pt 2): 1399-1406
9. Casas J, Friedman DF, Jackson T, Vege S, Westhoff CM, Chou ST. Changing practice: red blood cell typing by molecular methods for patients with sickle cell disease. Transfusion. 2015;55(6 pt 2): 1388-1393.
10. Chou ST, Flanagan JM, Vege S, et al. Whole-exome sequencing for RH genotyping and alloimmunization risk in children with sickle cell anemia. Blood Adv. 2017;1(18): 1414-1422.